The FDA’s committee recommended the Novavax vaccine for use in the U.S. on Tuesday.
FDA authorization would allow Novavax to start shipping doses to the U.S. from its manufacturing partner Serum Institute of India. However, the Centers for Disease Control and Prevention would still need to sign off on the vaccine before pharmacies and other health-care providers could start administering the shots.
Novavax asked the FDA to authorize its two-dose vaccine in late January. Dr. Doran Fink, a senior official at the FDA's vaccine division, told CDC advisors in April that reviewing Novavax's application has been"incredibly complex" because it involves clinical and manufacturing data.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
FDA advisers back Novavax COVID-19 vaccine as 4th option for US adultsA more traditional kind of COVID-19 vaccine is a step closer to becoming the fourth option for U.S. adults.
Baca lebih lajut »
FDA advisers back Novavax COVID shots as 4th US optionAmerican adults who haven’t yet gotten vaccinated against COVID-19 may soon get another choice, as advisers to the Food and Drug Administration on Tuesday backed a more traditional type of shot.
Baca lebih lajut »
FDA advisers back Novavax COVID-19 shots as new US optionAmerican adults who haven’t yet gotten vaccinated against COVID-19 may soon get another choice, as advisers to the Food and Drug Administration on Tuesday backed a more traditional type of shot.
Baca lebih lajut »
FDA advisers vote to recommend Novavax Covid-19 vaccineAdvisers signaled interest in making available a vaccine made with a technology different from the messenger RNA shots that have dominated the U.S. immunization arsenal against the disease.
Baca lebih lajut »
FDA panel greenlights Novavax COVID-19 vaccineFDA's vaccine chief said another choice in the U.S. may entice at least some vaccine holdouts - whatever their reason - to consider rolling up their sleeves. FOX13
Baca lebih lajut »
FDA advisory panel to consider approving fourth COVID-19 vaccine, this one from Maryland's NovavaxDevelopment of the vaccine, from Novavax, a Gaithersburg, Maryland-based company, was started at the same time as others in 2020, but the company struggled to produce its shot in large quantities.
Baca lebih lajut »